Cabozantinib: A narrative drug review
2023 · Cancer Research Statistics and Treatment · 9 citations
https://doi.org/10.4103/crst.crst_9_23
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
9
Citations
1
h-index
0
i10-index
Vivek K. Srigadha is an academic researcher from Tata Memorial Hospital. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Uterine Myomas and Treatments & Lung Cancer Diagnosis and Treatment. The author has an h-index of 1, co-authored 4 publications.
Click to start Chat